| Diffusion tensor imaging in preclinical and presymptomatic carriers of familial Alzheimer's disease mutations JM Ringman, J O’Neill, D Geschwind, L Medina, LG Apostolova, ... Brain 130 (7), 1767-1776, 2007 | 297 | 2007 |
| Biochemical markers in persons with preclinical familial Alzheimer disease JM Ringman, SG Younkin, D Pratico, W Seltzer, GM Cole, DH Geschwind, ... Neurology 71 (2), 85-92, 2008 | 246 | 2008 |
| Cortical event-related potentials in preclinical familial Alzheimer disease EJ Golob, JM Ringman, R Irimajiri, S Bright, B Schaffer, LD Medina, ... Neurology 73 (20), 1649-1655, 2009 | 123 | 2009 |
| The A431E mutation in PSEN1 causing Familial Alzheimer’s Disease originating in Jalisco State, Mexico: an additional fifteen families J Murrell, B Ghetti, E Cochran, MA Macias-Islas, L Medina, A Varpetian, ... Neurogenetics 7, 277-279, 2006 | 77 | 2006 |
| Education differentially contributes to cognitive reserve across racial/ethnic groups JF Avila, MA Rentería, RN Jones, JMJ Vonk, I Turney, K Sol, D Seblova, ... Alzheimer's & Dementia 17 (1), 70-80, 2021 | 74 | 2021 |
| Regional brain volume differences in symptomatic and presymptomatic carriers of familial Alzheimer's disease mutations GJ Lee, PH Lu, LD Medina, Y Rodriguez-Agudelo, S Melchor, G Coppola, ... Journal of Neurology, Neurosurgery & Psychiatry 84 (2), 154-162, 2013 | 63 | 2013 |
| Cerebrospinal fluid biomarkers and proximity to diagnosis in preclinical familial Alzheimer’s disease JM Ringman, G Coppola, D Elashoff, Y Rodriguez-Agudelo, LD Medina, ... Dementia and geriatric cognitive disorders 33 (1), 1-5, 2012 | 52 | 2012 |
| Current concepts of mild cognitive impairment and their applicability to persons at-risk for familial Alzheimer's disease JM Ringman, LD Medina, Y Rodriguez-Agudelo, M Chavez, P Lu, ... Current Alzheimer Research 6 (4), 341-346, 2009 | 50 | 2009 |
| Cortical and hippocampal atrophy in patients with autosomal dominant familial Alzheimer’s disease LG Apostolova, KS Hwang, LD Medina, AE Green, MN Braskie, RA Dutton, ... Dementia and geriatric cognitive disorders 32 (2), 118-125, 2011 | 43 | 2011 |
| Biochemical, neuropathological, and neuroimaging characteristics of early-onset Alzheimer's disease due to a novel PSEN1 mutation JM Ringman, KH Gylys, LD Medina, M Fox, V Kepe, DL Flores, ... Neuroscience letters 487 (3), 287-292, 2011 | 40 | 2011 |
| Effects of risk genes on BOLD activation in presymptomatic carriers of familial Alzheimer's disease mutations during a novelty encoding task JM Ringman, LD Medina, M Braskie, Y Rodriguez-Agudelo, ... Cerebral Cortex 21 (4), 877-883, 2011 | 35 | 2011 |
| Increased fMRI signal with age in familial Alzheimer's disease mutation carriers MN Braskie, LD Medina, Y Rodriguez-Agudelo, DH Geschwind, ... Neurobiology of aging 33 (2), 424. e11-424. e21, 2012 | 33 | 2012 |
| Reporting of demographic variables in neuropsychological research: An update of O’Bryant et al.’s trends in the current literature LD Medina, S Torres, A Gioia, AO Lopez, J Wang, PT Cirino Journal of the International Neuropsychological Society 27 (5), 497-507, 2021 | 32 | 2021 |
| The impact of COVID-19 on the well-being and cognition of older adults living in the United States and Latin America GM Babulal, VL Torres, D Acosta, C Agüero, S Aguilar-Navarro, ... EClinicalMedicine 35, 2021 | 29 | 2021 |
| Increased prevalence of significant recurrent headache in preclinical familial Alzheimer’s disease mutation carriers JM Ringman, JD Romano, LD Medina, Y Rodriguez-Agudelo, B Schaffer, ... Dementia and geriatric cognitive disorders 25 (4), 380-384, 2008 | 25 | 2008 |
| 1H MRS spectroscopy in preclinical autosomal dominant Alzheimer disease E Joe, LD Medina, JM Ringman, J O’Neill Brain imaging and behavior 13, 925-932, 2019 | 24 | 2019 |
| Subjective cognitive concern in multiple sclerosis is associated with reduced thalamic and cortical gray matter volumes I Kletenik, E Alvarez, JM Honce, B Valdez, TL Vollmer, LD Medina Multiple Sclerosis Journal–Experimental, Translational and Clinical 5 (1 …, 2019 | 24 | 2019 |
| The impact of the availability of prevention studies on the desire to undergo predictive testing in persons at risk for autosomal dominant Alzheimer's disease M Hooper, JD Grill, Y Rodriguez-Agudelo, LD Medina, M Fox, ... Contemporary clinical trials 36 (1), 256-262, 2013 | 23 | 2013 |
| Validation of a performance‐based assessment of cognitive functional ability in Parkinson's disease SK Holden, LD Medina, B Hoyt, SH Sillau, BD Berman, JG Goldman, ... Movement Disorders 33 (11), 1760-1768, 2018 | 22 | 2018 |
| Addressing the disparities in dementia risk, early detection and care in Latino populations: Highlights from the second Latinos & Alzheimer's Symposium YT Quiroz, M Solis, MP Aranda, AI Arbaje, M Arroyo‐Miranda, LY Cabrera, ... Alzheimer's & Dementia 18 (9), 1677-1686, 2022 | 21 | 2022 |
Jeffrey CummingsCleveland Clinic Lou Ruvo Center for Brain HealthПідтверджена електронна адреса в ccf.org
